Mitochon Pharmaceuticals focuses on neurodegenerative and neuromuscular diseases such as Huntington's, Alzheimer's, Parkinson's, and Duchenne Muscular Dystrophy. Their research has linked these diseases to mitochondrial malfunctions, and by correcting them, Mitochon aims to introduce disease-modifying therapies. Led by experienced industry executives, the company strives to bring breakthrough drug therapies for devastating diseases.